News & Updates
Showing Paediatrics articles
Showing
Show Multimedia Only

Lebrikizumab–topical corticosteroid combo improves outcomes in moderate-to-severe AD
16 Jan 2023
byJairia Dela Cruz
Treatment with lebrikizumab, when combined with low- to mid-potency topical corticosteroid (TCS), helps reduce disease severity in adolescent and adult patients with moderate-to-severe atopic dermatitis (AD), with a safety profile consistent with that reported in previous AD studies, according to the phase III ADhere trial.
16 Jan 2023

Modified Atkins diet helps control drug-resistant epilepsy
12 Jan 2023
byJairia Dela Cruz
Teen and adult patients with drug-resistant epilepsy may benefit from modified Atkins diet, which has been shown in a recent study to produce improvements in seizure frequency, quality of life (QOL), and behavioural problems as compared with standard drug therapy.
12 Jan 2023






